Alzheimer’s Disease

Have you or a loved one been diagnosed with Alzheimer’s disease? Are you experiencing troubles with your memory? You may be eligible for a no-cost memory screen to participate in a clinical research trial.

Below you’ll find the clinical trials we are currently enrolling participants in or will be soon.

• Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia (Bio-Hermes-002).
  • The purpose of the 120-day cross-sectional study will result in a blood, CSF, retinal, digital, MRI, and PET brain imaging biomarker database that can be used to determine whether a meaningful relationship exists between biomarkers alone or in combination with tau or amyloid brain pathology identified through PET images. 
  • ClinicalTrials.gov Identifier: NCT06584357
• A Pivotal Study of Sensory Stimulation in Alzheimer’s Disease (Hope Study, CA-0011)
  • The purpose of this study is to test if the daily use of a device called the ‘Sensory Stimulation System’ can help in slowing the progression of Alzheimer’s-memory related issues. The device provides sensory stimulation via over-the-eye glasses and over-the-ear headphones for, up to, several hours daily.
  • ClinicalTrials.gov Identifier: NCT05637801
• Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer’s Disease (TargetTau-1)
  • The purpose of this study is to assess the effectiveness, safety, and tolerability of a drug (BMS-986446) in participants with Early Alzheimer’s disease. This study is for those with Mild Cognitive Impairment (MCI) or Mild Alzheimer’s disease.
  • ClinicalTrials.gov Identifier: NCT06268886